Tag: Q’Apel Medical

Q’Apel Medical Raises $22 Million to Grow Highly Innovative Neurovascular Access Platform & Scott Huennekens Joins Board of Directors

Investment Will Be Used to Scale Product Platform, Expand Nationally, Internationally and Grow Team FREMONT, Calif., Feb. 11, 2021 /PRNewswire/ — Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today it has raised $22 Million in Series C funding. The round included […]